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including optical methods (Dunn et al., 2005; Grant et al., 2009; 
Roche-Labarbe et al., 2010) and tissue oxygenation measurements 
in animal studies (Caesar et al., 2008; Piilgaard and Lauritzen, 2009; 
Thomsen et al., 2009), also exploit the change in blood or tissue 
oxygenation due to the mismatch of CBF and CMRO2 changes as 
a biomarker of altered neural activity.
Because oxygenation changes depend on the relative changes in 
CBF and CMRO2, a quantitative interpretation of BOLD signals, 
and also other functional neuroimaging signals related to blood 
or tissue oxygenation, is fundamentally limited until we better 
understand brain oxygen metabolism and how it is related to blood 
flow. While there has been a large research effort focused on the 
links between neural activity and blood flow, our understanding of 
oxygen metabolism changes is limited by the intrinsic difficulty of 
measuring CMRO2. However, the complexity of oxygenation signals 
also has a positive side: the fact that oxygenation signals are sensitive 
to both CBF and CMRO2 changes offers the possibility of estimat-
ing CMRO2 changes when these measurements are combined with 
additional measurements of CBF. In fact, a quantitative interpreta-
tion of oxygenation-based signals offers the best hope we have for 
measuring dynamic changes in CMRO2 (Herman et al., 2009). This 
is intrinsically a multimodal imaging approach, and a key required 
element to make it work is a theoretical framework that accurately 
relates our measured signals to the underlying physiology.
IntroductIon
A brief neural stimulus produces a rapid and robust increase of 
cerebral blood flow (CBF), as illustrated in Figure 1A. Although this 
phenomenon is the basis for most current functional neuroimaging 
methods, it is still not clear what physiological function this serves. 
The CBF response is quite strong, with the fractional CBF change 
typically ∼2–4 times larger than the associated fractional change 
in the cerebral metabolic rate of oxygen (CMRO2). A useful way of 
describing this effect is that the oxygen extraction fraction (OEF) – 
the fraction of delivered oxygen that is extracted from the blood 
and metabolized – decreases with increased neural activity. This 
counterintuitive result, first reported by Fox and Raichle (1986), 
is surprising because at rest CBF and CMRO2 appear to be tightly 
coupled, with a relatively uniform OEF across the brain despite a 
wide regional variation of blood flow (Gusnard and Raichle, 2001). 
Fortunately for the field of functional neuroimaging, the increase of 
local blood oxygenation with activation produces a small increase 
of the signal measured with functional magnetic resonance imaging 
(fMRI) because of the magnetic properties of deoxyhemoglobin, 
with higher deoxyhemoglobin levels tending to reduce the MR 
signal. Decreased deoxyhemoglobin due to the drop in OEF with 
activation then leads to an increase of the MR signal, the blood 
oxygenation level dependent (BOLD) response (Kwong et al., 1992; 
Ogawa et al., 1992; Buxton, 2009) (Figure 1B). Other techniques, 
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This  review  focuses  on  the  problem  of  interpreting 
  oxygenation-based signals, the challenges involved in measuring 
CMRO2 in general, and what is needed to put oxygenation-based 
estimates of CMRO2 on a firm foundation. The importance of 
developing a solid theoretical framework is emphasized, both as an 
essential tool for analyzing oxygenation-based multimodal meas-
urements, and also potentially as a way to better understand the 
physiological phenomenon that lies at the heart of BOLD-fMRI: 
the mismatch of CBF and CMRO2 changes with activation.
the problem: can we Interpret oxygenatIon-based 
sIgnals as a quantItatIve reflectIon of 
physIologIcal actIvIty?
Functional MRI based on mapping the BOLD response has devel-
oped into a widely used and sensitive tool for mapping patterns 
of activation in the human brain. Sophisticated statistical meth-
ods have been developed to identify significant signal changes 
associated with a stimulus, and these detected changes are taken 
as evidence for a change in neural activity at that location (with 
the caveat that the changes in deoxyhemoglobin may be domi-
nated by downstream venous vessels that could be displaced from 
the precise site of neural activity change). This robust mapping 
approach addresses the basic question: where does activity occur? 
However, an important challenge facing functional neuroimaging 
is to move beyond mapping to meaningfully address the question 
of quantifying the activity change. This is a distinctly different, and 
much harder, problem than simply identifying where a change 
has occurred.
The key question is: does the magnitude of the BOLD response 
quantitatively reflect the magnitude of the underlying physiological 
changes? There are two primary effects that could alter the BOLD 
signal even for the same underlying change in neural activity: the 
baseline CBF state, and the coupling of CBF and CMRO2 changes. 
The BOLD response has a ceiling, corresponding to complete 
removal of deoxyhemoglobin, and so the amount of deoxyhemo-
globin present in the baseline state sets the possible dynamic range 
for the BOLD response (Brown et al., 2003). This baseline effect 
could be an important confounding factor when studying disease 
populations, where the baseline CBF and CMRO2 may be altered 
by medications or by chronic aspects of the disease process itself 
(Fleisher et al., 2009). The second effect, that has received less atten-
tion to date, is that the BOLD response is sensitive to the exact 
coupling of CBF and CMRO2 (Ances et al., 2008; Herman et al., 
2009). That is, methods sensitive to blood or tissue oxygenation 
depend on the relative balance of the changes in CBF and CMRO2. 
Increased neural activity drives increases in both blood flow and 
oxygen metabolism, but these physiological changes drive blood 
oxygenation in opposite directions.
The magnitude of the BOLD response thus depends on the 
CBF/CMRO2 coupling ratio n, defined as the ratio of the frac-
tional change in CBF to the fractional change in CMRO2 for a given 
stimulus. This would not be a problem for interpreting the BOLD 
response if n is fixed. For example, a simple picture would be that 
increased neural activity requires increased energy metabolism, and 
the increased CMRO2 then drives an increase in CBF in a fixed ratio. 
However, a large body of evidence supports an alternative view 
that aspects of neural signaling, such as neurotransmitter release, 
nitric oxide (NO) generation, extracellular potassium changes, 
and activation of arachidonic acid pathways, can either dilate or 
constrict the blood vessels (Attwell and Iadecola, 2002; Hamel, 
2006). In particular, the astrocytes, with processes projecting to 
both neuronal synapses and blood vessels, are thought to play a 
key role in detecting synaptic activity and modulating blood flow 
(Iadecola and Nedergaard, 2007; Koehler et al., 2009). In short, it is 
likely that the rapid control of CBF is driven by fast feed-forward 
mechanisms related to the neural activity itself, rather than feed-
back mechanisms related to energy metabolism. In other words, 
it appears that CBF and CMRO2 changes are driven in parallel by 
neural activity.
This raises the critical question: which aspects of neural activity 
drive CMRO2, which drive CBF, and are they always in the same 
ratio? The energy cost of neural activity is primarily in restoring 
ionic gradients following neural signaling, fueled by increased ATP 
consumption, and the ATP is replenished by the oxidative metabo-
lism of glucose (Attwell and Laughlin, 2001). The focus here is on 
O2 metabolism, because CMRO2 is the relevant metabolic rate that 
combines with CBF to alter blood and tissue oxygenation. Clearly, 
though, CMRO2 requires glucose metabolism, because glucose is 
the substrate that is oxidized. Positron emission tomography (PET) 
studies typically find that the fractional change of the cerebral 
metabolic rate of glucose (CMRGlc) more closely follows the frac-
tional CBF change and is larger than the fractional CMRO2 change 
(Fox et al., 1988). However, the link between CBF and CMRGlc 
is not tight, in that CMRGlc changes occur even when the CBF 
response is blocked (Cholet et al., 1997), and a recent study found 
Figure 1 | CBF and BOLD responses to a brief stimulus in human 
subjects. (A) Two seconds of finger tapping evoke a strong CBF change in 
primary motor cortex, measured here with an arterial spin labeling (ASL) MRI 
method. (B) The CBF change is accompanied by a local increase in blood 
oxygenation, giving rise to the BOLD response measured with fMRI. Because 
of the nature of the measurements, BOLD-fMRI has intrinsically higher 
sensitivity than ASL, despite the small magnitude of the signal changes. Data 
from Miller et al. (2001).Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 8  |  3
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For measuring CMRGlc there is also an accepted standard based 
on injection of radioactively labeled deoxyglucose, a chemically 
modified form of glucose (Sokoloff et al., 1977; Phelps et al., 1981). 
Deoxyglucose is taken up from the blood like glucose and binds 
to the enzyme hexokinase, the first step in the glycolysis pathway. 
However, because of the structural difference between glucose and 
deoxyglucose, the latter cannot proceed to the later stages of gly-
colysis, and essentially sticks in the tissue. By waiting sufficiently 
long for unmetabolized deoxyglucose to diffuse back into blood 
and clear from the tissue, the remaining radioactive label in tissue 
directly reflects the local rate of metabolism of deoxyglucose, and 
can be quantified by also measuring the arterial concentration curve 
of the agent during delivery. This approach is applied in humans 
with PET using deoxyglucose labeled with  18F, a positron emit-
ting radionuclide. As with microspheres for CBF measurement, 
the reason this technique works so well is that a single measure-
ment of the tissue concentration of the agent directly reflects the 
metabolic rate.
Oxygen dynamics in the tissue can be measured by injecting 
labeled O2, either with 15O for PET detection (Mintun et al., 1984) 
or 17O for NMR detection (Arai et al., 1990, 1991; Fiat and Kang, 
1992, 1993). However, deriving CMRO2 from such measurements 
is surprisingly difficult. The essential problem is that one cannot 
tell whether the detected oxygen nucleus is in O2, and thus not 
metabolized, or in water, and thus metabolized. Imagine measuring 
tissue concentration as a function of time during and following 
an injection of labeled O2. Initially, the labeled oxygen nucleus 
detected in the tissue will be in the form O2. Because the solubility 
of O2 in extravascular tissue is very low compared to blood due to 
hemoglobin binding, most of the labeled oxygen is in the blood 
compartment of the tissue, so that cerebral blood volume (CBV) 
strongly affects the measured concentration of labeled oxygen. Over 
time some of the initially delivered O2 will diffuse back to the blood 
without being metabolized and clear from the tissue. Another com-
ponent will enter the mitochondria and be converted to water by 
oxygen metabolism. The labeled water will eventually diffuse to 
the blood and clear from the tissue. However, as blood continues 
to circulate the labeled water will be delivered back to the tissue, at 
a rate that depends on CBF, so that now the labeled oxygen enters 
as water as well as O2. In short, the kinetics of the labeled oxygen 
nucleus depends strongly on CBF and blood volume in addition to 
CMRO2, and there is no point in time when the tissue concentration 
cleanly reflects CMRO2 alone.
For this reason, the current standard method for measuring 
CMRO2 with PET requires three separate measurements follow-
ing injection of 15O labeled O2, water, and carbon monoxide (for 
blood volume measurement), and analysis of the dynamic tissue 
concentration curves within a theoretical framework that accounts 
for the combined effects of CMRO2, CBF and CBV on the observed 
tracer kinetics (Mintun et al., 1984). In addition, temporal sampling 
of arterial blood is needed to measure the arterial time course of 
labeled O2 and labeled water. Even with these combined measure-
ments it is still necessary to assume that there is no back flux of 
unmetabolized O2 from tissue to blood, specifically that all the O2 
that leaves the capillary is metabolized. For both PET and NMR 
studies a number of ideas have been proposed for simplifying 
these measurements, but each of these is sensitive to particular 
an uncoupling of CBF and CMRGlc related to inhibition (Devor 
et al., 2008). A larger fractional change in CMRGlc compared to 
CMRO2 suggests that there is some degree of aerobic glycolysis and 
a corresponding generation of lactate despite an abundance of 
available oxygen (Prichard et al., 1991). The term aerobic glyco-
lysis emphasizes the distinction to anaerobic glycolysis, in which 
reduced  O2  availability  prevents  oxidative  metabolism  of  the 
pyruvate created by glycolysis, and the pyruvate is subsequently 
converted to lactate. When oxygen is not available, glycolysis can 
provide a source of ATP. However, glycolysis alone generates less 
than 1/15 of the ATP generated by full oxidative metabolism, so 
the additional ATP generated by the aerobic glycolysis in the well-
oxygenated healthy brain is a small fraction of the increased ATP 
generated by the smaller increase of oxidative metabolism. It is 
still unclear how aerobic glycolysis fits into the metabolic side of 
neural activation (Paulson et al., 2010), particularly because the 
contribution to energy metabolism is small. The rest of this review 
focuses on CMRO2, with the assumption that it is not limited by 
the availability of glucose.
It is likely that CMRO2 simply responds as needed to match ATP 
production to ATP consumption, so that the increase of CMRO2 
reflects the overall energy cost of the evoked neural activity. In 
contrast, if the CBF response is driven by feed-forward mechanisms 
related to the neural signaling itself, this opens the possibility that 
the coupling index n is not fixed. As discussed below, a number of 
studies suggest that n varies regionally and even within the same 
region as the stimulus changes. Typical values are in the range 
n ∼ 2–4, and unfortunately this is a range in which the BOLD 
response magnitude is expected to be sensitive to the exact value of 
n. For example, theoretical calculations indicate that for the same 
CMRO2 change (and by assumption the same overall evoked neural 
activity), the BOLD response magnitude differs by 100% for n = 2 
compared with n = 3 (Ances et al., 2008).
the challengIng task of measurIng cmro2
measurIng cmro2 wIth labeled oxygen
In contrast to CMRO2, there are relatively direct and robust ways 
to measure CBF and CMRGlc. For these measurements, techniques 
have been developed in which a single agent is injected, allowed 
to distribute through the brain, and a single measurement of the 
concentration of the agent then provides a direct measure of the 
appropriate physiological quantity (CBF or CMRGlc). The accepted 
standard for CBF measurements is a microsphere experiment, in 
which labeled microspheres are injected arterially. Because the 
microspheres are too large to pass through the capillaries, they 
stick in the tissue, and the local concentration of microspheres then 
directly reflects the local CBF. With an appropriate measurement 
of the injected arterial bolus, the local CBF can be quantified in 
absolute units of ml blood/ml tissue/min. While microspheres are 
not used in human subjects, microsphere techniques provide the 
classic “gold standard” for validating other methods for measuring 
CBF. For human studies with MRI, pulsed arterial spin labeling 
(ASL) methods approach the ideal microsphere experiment because 
the delivery of magnetically labeled blood is measured only ∼1.5 s 
after creation of the labeled blood in the arteries, so there is little 
time for the labeled blood to pass through the capillary bed and 
clear from tissue (Buxton, 2005).Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 8  |  4
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with a separate measurement of CBF then provides an estimate of 
baseline CMRO2. When this measurement is done in the sagittal 
sinus the result is a whole-brain CMRO2 estimate, but if this tech-
nique can be adapted for regional measurements it will provide 
important information on the distribution of baseline CMRO2. 
Even as a whole-brain measurement, baseline venous oxygenation 
can account for a significant amount of the variance of the BOLD 
response between subjects (Lu et al., 2010). The second method 
exploits a detailed model of how R2 changes with time as the MR 
signal decays, with the essential assumption that the additional 
signal decay in a gradient echo measurement compared with a spin 
echo measurement is entirely due to the effects of deoxyhemoglobin 
(Yablonskiy and Haacke, 1994; He and Yablonskiy, 2007; He et al., 
2008). With additional assumptions about properties of the tissue 
compartments, this approach gave estimates of baseline O2 extrac-
tion fraction that are in good agreement with PET measurements. 
As these methods mature they may provide an important comple-
ment to the dynamic methods discussed below by providing the 
link between fractional and absolute changes in CMRO2.
An essential component of BOLD and tissue pO2 methods is 
a theoretical framework that accurately relates CBF and CMRO2 
changes to the measured oxygenation signal. Modeling these physi-
ological variables, in terms of how they relate to each other and in 
terms of how they relate to the imaging signals, is an active area 
of research (Valabregue et al., 2003; Buxton et al., 2004; Gjedde, 
2005a,b; Huppert et al., 2007, 2009; Uludag et al., 2009; Zheng et al., 
2010). To clarify how such a theoretical framework can be used to 
estimate CMRO2 changes, we focus here on the simple theoretical 
framework defined in Table 1, which relates, CBF, CMRO2, the 
BOLD signal, and tissue pO2. In this framework, changes in CBF 
and CMRO2 are related to the BOLD response by Eqs 1,2, and to the 
tissue pO2 response by Eqs 1, 3, and 4. In this framework, Eq. 1 is 
the most solid, essentially just reflecting mass balance. The product 
of flow and arterial O2 concentration is the rate of delivery of O2 
to the capillary bed, and multiplying by the fraction of delivered 
O2 that is metabolized gives CMRO2. The remaining equations, 
however, represent specific models.
Modeling the BOLD response
Equation 2 is a model for the BOLD response proposed by Davis et al. 
(1998), based on physical reasoning and Monte Carlo simulations. 
This is a simple model of a complex phenomenon, and yet this model 
has proven to be more robust than one might have thought given 
the restrictive assumptions that went into its derivation. Although 
originally derived just from consideration of extravascular signal 
changes, it captures the basic behavior of more detailed models 
that include additional effects (discussed below). The model reflects 
the primary dependence of the BOLD signal on changes in the O2 
extraction fraction, but also includes an additional term in f that is 
intended to model the effect of blood volume changes on the BOLD 
signal as a power law relation with CBF, with an empirical exponent 
α = 0.4 (Grubb et al., 1974). The role of blood volume changes in 
modulating the observed BOLD response is somewhat subtle, and 
we still do not have a satisfactory understanding. In principle, blood 
volume changes could influence the BOLD response by changing 
the local total deoxyhemoglobin in tissue independently of a change 
in blood oxygenation. That is, blood oxygenation determines the 
  assumptions of the model (Ohta et al., 1992; Zhu et al., 2002, 2005, 
2006; Ibaraki et al., 2004; Zhang et al., 2004; Kudomi et al., 2007, 
2009). In short, the complexity of these studies reflects the intrinsic 
difficulty of measuring local O2 metabolism, and emphasizes the 
need for an accurate theoretical framework to integrate the differ-
ent measurements. Furthermore, as with all studies using injected 
tracers, the assumption is that the physiology is in a steady-state 
throughout the measurement so that the observed dynamics of the 
agent reflect the dynamics of the injected bolus and its transport to 
tissue. For this reason the measurements of CMRO2 are necessarily 
steady-state rather than dynamic. Despite the complexities of the 
technique, PET measurement of CMRO2 is now being done at a 
number of institutions, although usually as a baseline measurement 
in different clinical conditions. Applications looking at brain activa-
tion in healthy subjects are less common (Mintun et al., 2002).
Another NMR approach for measuring CMRO2 exploits a par-
ticular magnetic property of 17O: when incorporated into a water 
molecule, it acts as a relaxation agent, altering the relaxation times 
of hydrogen nuclei. Furthermore, this effect can be modulated by 
applying a radiofrequency pulse at the 17O resonance frequency 
(Ronen and Navon, 1994; Ronen et al., 1997, 1998). In this way 
the presence of 17O labeled water can be detected with standard 
proton MRI as a change in relaxation rate. However, when the 17O 
is incorporated into an O2 molecule it does not have this relaxation 
property. This creates the interesting scenario in which 17O inhaled 
as O2 is not visible with standard proton MRI until the 17O has been 
incorporated into water by O2 metabolism in the mitochondria. 
The rate of appearance of labeled water is then proportional to 
local CMRO2. To quantify this, however, requires additional meas-
urement of the arterial input function (concentration of the label 
in arterial blood), and accounting for recirculation of the labeled 
water. Despite early interest in this approach, it has not been widely 
used to date due to the complexity involved in addressing these 
issues (similar to issues in the PET studies described earlier), com-
bined with the high cost of 17O, although a recent study has extended 
the method to larger animals (Mellon et al., 2009).
measurIng cmro2 from blood or tIssue oxygenatIon
The alternative to the more classical tracer kinetics approaches 
described above is to use blood or tissue oxygenation in combina-
tion with a measurement of CBF to estimate a change in CMRO2. 
This section focuses on the calibrated-BOLD approach, the primary 
method used in human studies, and tissue pO2 measurements used 
in animal studies. These two approaches are primarily sensitive to 
changes in CMRO2. Although these methods are not as sensitive 
to the baseline CMRO2 value, they provide the best opportunity 
available to measure the dynamics of CMRO2.
Before discussing these methods, though, it is important to 
note briefly that two recent alternative MRI approaches have been 
proposed that potentially could provide estimates of baseline abso-
lute CMRO2. Both focus on the question of estimating the venous 
oxygenation through its effect on the transverse relaxation rate 
R2. With TRUST, the signal in a draining vein such as the sagittal 
sinus is isolated with an approach similar to ASL, and the trans-
verse relaxation rate R2 is measured (Lu and Ge, 2008; Xu et al., 
2009). From calibration studies in blood samples, R2 varies with O2 
saturation. Combining this estimate of venous O2 concentration Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 8  |  5
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a signal difference due to an exchange of one volume for another 
carrying a different signal is amplified in the VASO technique for 
measuring blood volume changes, by nulling the magnetization of 
blood to increase the intrinsic signal difference between the intra-
vascular and extravascular spaces (Lu et al., 2003), although the full 
mechanisms of signal change with VASO are likely more complicated 
(Donahue et al., 2006, 2009). Although this effect is much weaker in 
the BOLD response, it is good to remember that the BOLD response 
is not purely oxygenation-dependent.
The  BOLD  signal  model  in  Eq.  2  contains  two  additional 
parameters, β and M. The exponent β was derived from Monte 
Carlo simulations of spins diffusing around magnetized cylinders 
(Boxerman et al., 1995b), and essentially captures the idea that 
the same amount of deoxyhemoglobin has less of an effect on the 
BOLD signal change when it is in capillaries compared to when 
it is in larger veins (Ogawa et al., 1993). The source of this effect 
is the random movement of water molecules due to diffusion. It 
happens that the magnitude of motion of a water molecule during 
an experiment is comparable to the diameter of a capillary, so near 
the smallest vessels each molecule will sample a range of field offsets. 
Because all the water molecules are essentially sampling the same 
range of field offsets, the net phase dispersion when the net signal 
is measured is not as great as it would be if the molecules had not 
moved around. The net phase dispersion translates directly into 
the measured signal change, so the signal change is larger around 
larger vessels, where diffusion is less important because of the larger 
spatial scale of the field offsets. From numerical simulations, β = 1.5 
approximately captures these effects for 1.5 T, decreasing to a value 
near 1 at high fields. Although this simple model ignores several 
effects, such as intravascular signal changes (Boxerman et al., 1995a) 
and volume exchange effects, it agrees reasonably well with models 
that explicitly include these effects (Buxton et al., 1998, 2004; Obata 
et al., 2004; Leontiev et al., 2007).
The parameter M is an overall scaling factor that essentially 
depends on the amount of deoxyhemoglobin present in the baseline 
state, as well as details of the image acquisition method such as the 
field strength and echo time (Davis et al., 1998; Buxton et al., 2004). 
This parameter sets the maximum possible BOLD signal ampli-
tude for that region of brain, corresponding to complete removal 
of deoxyhemoglobin. That is, it is important to remember that 
the BOLD response has a ceiling, and that ceiling is reflected in 
M. Unlike the parameters α and β, which are usually assumed to 
be constant, the parameter M must be measured for each brain 
location for the particular experimental acquisition. This is done 
in the calibrated-BOLD approach introduced by Davis et al. (1998) 
by also measuring the BOLD and CBF responses to breathing CO2. 
The CBF response is measured with an ASL technique (Detre et al., 
1992; Wong et al., 1997) and the essential idea is to exploit the fact 
that the ASL signal depends just on CBF changes, while the BOLD 
signal depends on CBF and CMRO2 changes. Mild hypercapnia 
is thought to produce a large change in CBF without changing 
CMRO2 (Sicard and Duong, 2005) (although there is still some 
controversy about this assumption; Zappe et al., 2008), and Eq. 2 is 
used to calculate M for a particular brain region with the assump-
tion that r = 1. With M estimated, the measured CBF and BOLD 
responses to stimulus activation are used with Eq. 2 to derive an 
estimate of r, the fractional change in CMRO2.
deoxyhemoglobin concentration in blood, but total deoxyhemo-
globin also depends on the volume of the blood compartments 
that contain partially deoxygenated blood. This is usually thought 
of as “venous” blood, but really also includes capillary and to some 
extent arteriolar blood, because it is thought that arteriolar blood is 
already slightly deoxygenated. Blood volume changes also can affect 
the measured BOLD response by a pure exchange of volumes, an 
effect that is not related to blood oxygenation. For example, a blood 
volume increase on the arterial side should have little effect on total 
deoxyhemoglobin, but if the increased blood volume occurs at the 
expense of a reduced extravascular volume, then the measured signal 
could change due to an intrinsic signal difference between the blood 
and the extravascular material that is displaced. This basic effect of 
Table 1 | Simple theoretical framework for estimating CMrO2 from 
multimodal measurements.
Theoretical Framework
VAriABLeS
   f  = CBF normalized to baseline
   r  = CMRO2 normalized to baseline 
   s  = BOLD signal normalized to baseline
   E  = O2 extraction fraction
   p C = mean blood pO2 (mmHg)
   p T = mean tissue pO2 (mmHg)
requireD BASeLiNe  pArAMeTerS (TypiCAL VALueS)
   E 0 = 0.4 
   p T0 = 25 mmHg 
MODeL pArAMeTerS 
   α = 0.4 (blood volume effects) 
   β = 1.5 (intravascular signal changes, diffusion)
   M  = local scaling factor, determined by calibration
   p 50 = 26 mmHg (O2-hemoglobin 50% saturation)
   h  = 2.8 (Hill exponent)
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The equations describe: (1) Mass balance for O2, expressed in terms of variables 
normalized to their baseline values; (2) Davis model for the BOLD signal, with 
the parameter α describing effects of blood volume changes, and β approxi-
mating differential diffusion effects around large and small vessels estimated 
from Monte Carlo simulations; (3) Assumption that the tissue/blood pO2 gradient 
increases to match a change in CMRO2, and that this gradient is determined 
solely by the difference of the mean O2 concentrations in blood and tissue (no 
capillary recruitment); and (4) Expression for mean blood pO2 assuming the Hill 
equation for the O2-hemoglobin saturation curve, with exponent h and half-sa-
turation at a pO2 of p50, and assuming that the pO2 corresponding to half of the 
total extracted O2 is the mean value for blood.Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 8  |  6
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producing a more pronounced undershoot of the BOLD response. 
This is just a simulated example, but it illustrates that the modeling 
framework predicts that relatively subtle differences in the CBF 
and CMRO2 responses can produce transient features of the BOLD 
response that are similar to those that often have been reported 
(Perthen et al., 2008).
Modeling tissue pO2 changes
In addition to signals related to blood oxygenation there is growing 
interest in using signals related to tissue oxygenation in animal mod-
els, including traditional microelectrode methods as well as newer 
methods (Ndubuizu and LaManna, 2007). Interestingly, though, 
blood and tissue oxygenation signals are not equivalent, and the 
theoretical framework helps to clarify the differences. The simple 
theoretical framework for interpreting tissue pO2 shown in Table 
1 is adapted from the work of Gjedde (2005a), although framed in 
a slightly different way (discussed below). The model is based on 
three key assumptions: (1) With increased activity there is no capil-
lary recruitment, so the vascular geometry stays the same. Increased 
CMRO2 requires an increased gradient of O2   concentration between 
A useful way to look at the role played by the BOLD model 
is that it allows us to draw contours of equal BOLD response in 
a plane defined by the fractional CMRO2 change on the x-axis 
and the fractional CBF change on the y-axis. Figure 2A shows an 
example for M = 0.08 (i.e., an 8% ceiling on the BOLD response 
magnitude). If the value of M is not known, these contours would 
reflect equal but unknown increments of the BOLD response. Note 
that the non-linearity of the BOLD signal model primarily affects 
the spacing of the contour lines, while each contour is reasonably 
linear. If we are willing to assume that Eq. 2 holds for dynamic 
as well as steady-state changes (more on this question below), a 
hypothetical trajectory of CBF and CMRO2 responses to a brief 
stimulus can be plotted in this plane along with the resulting BOLD 
response. An example is shown in Figure 2. Both CBF and CMRO2 
are assumed to exhibit a smoothed response, with two features 
added to illustrate how transients of the BOLD response could 
occur. The first feature is that the CMRO2 response has a slightly 
faster rise time than the CBF response, producing an initial dip of 
the BOLD response. The second feature is a slight undershoot of 
the CBF response after the stimulus before it returns to baseline, 
Figure 2 | Theoretical curves derived from the theoretical framework in 
Table 1. (A) Equations 1 and 2 define contours (in red) of equal BOLD signal 
change in the CBF/CMRO2 plane, here illustrated for M = 8%. The contour of 
zero BOLD response has a slope slightly greater than 1 because of the way 
blood volume effects are included. (B) Equations 1, 3, and 4 define contours (in 
blue) of equal tissue pO2 change, calculated with the assumption that at baseline 
pTO2 = 25 mmHg. (C) Hypothetical CBF and CMRO2 responses to a simple 
stimulus are shown. These two responses define a trajectory in the CBF/CMRO2 
plane, shown in (A,B) as the black curve. The points on the curve represent 
equal time increments in the evolving CBF and CMRO2 curves in (C). (D) The 
resulting BOLD and tissue pO2 responses are shown for the CBF and CMRO2 
responses in (C). Note that in this example the CBF and CMRO2 responses are 
approximately in the ratio 2:1 (i.e., n ∼ 2), and this causes the trajectory to pass 
over and under the zero change contour of pTO2, leading to the complex 
dynamics in (D). In addition, the CBF response was constructed with a weak 
post-stimulus undershoot to illustrate that this can create a more pronounced 
undershoot in the BOLD signal. In this example the ratio of the undershoot to 
the peak response is only ∼8% for CBF , but ∼30% for the BOLD response.Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 8  |  7
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The tissue pO2 model allows us to draw contours of equal tis-
sue pO2 in the plane defined by the fractional changes in CMRO2 
and CBF (Figure 2B). One clear feature of these contour lines is 
that they are distinctly different from the contours of the BOLD 
response. Specifically, the line of constant BOLD signal and the line 
of constant tissue pO2 have different slopes. This means that there 
is a range of possible CBF and CMRO2 responses, lying between 
the two zero change contour lines, where the BOLD response and 
the tissue pO2 response will have opposite signs (a negative tissue 
pO2 response occurring with a positive BOLD response). Again 
assuming that this model accurately describes dynamic changes 
as well as steady-state changes, the predicted variation of tissue 
pO2 for the hypothetical CBF and CMRO2 responses is shown in 
Figure 2D. Note that this response is quite complicated, with a more 
pronounced initial dip compared with the BOLD response, and a 
positive response that only begins after the end of the stimulus. 
This complex response shows features similar to the interesting 
variety of tissue pO2 responses that have recently been reported 
for different stimuli in animal models, including relatively simple 
positive responses to a strong stimulus (Ances et al., 2001), a pro-
nounced initial dip (Offenhauser et al., 2005) and complex wig-
gles and slow post-stimulus undershoots (Thompson et al., 2003, 
2004). The source of the complexity of the pO2 response is that the 
simulated CBF and CMRO2 responses have a ratio of about 2:1, and 
this means that the trajectory of the response passes back and forth 
across the zero contour of the tissue pO2 response. This is consist-
ent with the pO2 measurements of Thompson and colleagues, in 
which all of the pO2 fluctuations they reported were less than ∼5% 
of the baseline pO2. The potentially important implications of this 
are discussed further below.
ImprovIng and valIdatIng the theoretIcal framework
Validating the accuracy of the models
The  discussion  above  illustrates  that  an  appropriate  modeling 
framework can play two important roles. First, it provides a way 
to combine multimodal measurements (in this case CBF and BOLD 
responses, or CBF and tissue pO2 responses) to make a quantitative 
estimate of the CMRO2 response. Second, it provides a framework 
for exploring how different responses (e.g., BOLD and tissue pO2) 
will co-vary or diverge under different conditions. In particular, 
the  theoretical  framework  brings  out  significant  quantitative 
differences in the BOLD and tissue pO2 responses that are not 
intuitively obvious. Examples are the predictions that: (1) a slight 
post-  stimulus undershoot of CBF can produce a much more pro-
nounced undershoot of the BOLD response; (2) there are possible 
changes in which the BOLD and tissue pO2 responses will have 
opposite sign; and (3) the tissue pO2 response can be significantly 
more complicated than the underlying CBF and CMRO2 responses 
or the accompanying BOLD response. However, the theoretical 
framework outlined here is really just the starting point, and a 
number of possible limitations have to be tested, and the theoretical 
framework revised accordingly.
The BOLD signal model has several potentially important limi-
tations. Although it was argued above that the current model is 
more robust than one might conclude from the restrictive assump-
tions involved in its derivation, this needs to be further tested. 
In particular, the most important aspect to nail down is the role 
blood and tissue, and if the vessel geometry is fixed this increased 
gradient must be due to an increased difference between blood 
and tissue pO2 values, leading to Eq. 3. (2) The O2 saturation Y of 
hemoglobin as a function of pO2 is described by the Hill equation 
with exponent h and half-saturation value p50, the pO2 at which 
hemoglobin is 50% saturated: Y = 1/[1 + (p50/pO2)h]. The values 
for h and p50 for human blood in Table 1 are taken from Mintun 
et al. (2001), but Gjedde (2005a) has suggested using higher values 
of p50 = 35 mmHg and h = 3.5 to approximate the Bohr effect. (3) 
The mean blood pO2 driving diffusion into the tissue is the value 
derived from the Hill equation when the total O2 concentration is 
halfway to the full extraction fraction from the blood given by E. 
Equations 1, 3, and 4 effectively provide two relationships between 
the four physiological variables CBF, CMRO2, E and tissue pO2. In 
this way measuring any two of these variables allows one to calculate 
the remaining two from the equations. Specifically, measuring tissue 
pO2 and CBF allows calculation of CMRO2 and E.
At first glance the formulation in Table 1 may seem surprising, 
because it does not include any of the microscopic parameters 
that are usually introduced in analyzing O2 diffusion into tissue 
(Gjedde, 2005a; Caesar et al., 2008). For example, the classic Krogh 
cylinder model is framed in terms of parameters such as the O2 
diffusion constant, capillary radius and capillary spacing (Mintun 
et al., 2001). Instead, the goal here was to define the framework in 
terms of macroscopic variables, with introduction of as few micro-
scopic variables as possible, because the microscopic parameters 
may not be well known. For example, the exact value of the O2 
diffusivity does not enter the equations because it is assumed to be 
constant and effectively cancels out from Eq. 3. Instead of referenc-
ing the model parameters to microscopic parameters, the model is 
anchored by specifying baseline values of the macroscopic variables. 
In this case, one must specify E and tissue pO2 in the baseline state, 
and combined with Eq. 3 this gives the baseline mean blood pO2. 
The key difference between the current formulation, and the previ-
ous formulation used to interpret pO2 measurements (Caesar et al., 
2008; Piilgaard and Lauritzen, 2009; Thomsen et al., 2009), is that 
this approach allows one to relate fractional changes in CMRO2 to 
pO2 without assuming values for microscopic variables, while the 
previous formulation focused on relating pO2 to absolute CMRO2, 
which requires accurate knowledge of microscopic O2 diffusivity.
In short, the formulation in Table 1 exploits the general phe-
nomenon of levels of description: not all of the variables that 
need to be specified in a microscopic modeling framework will 
carry through to affect macroscopic parameters. By anchoring the 
model to assumptions about the baseline values of the macro-
scopic parameters we essentially fine-tune the relevant microscopic 
parameters to produce that baseline state, without ever introducing 
those microscopic parameters explicitly. Importantly, this approach 
also effectively allows the model to be adjusted to the human brain 
without having to assume that microscopic parameters measured 
in animal models carry through precisely to humans. In this case, 
there are a number of PET measurements of E in human subjects 
that suggest a baseline value of 0.4 is reasonable. For baseline tis-
sue pO2 there is considerable variability in the tissue (discussed 
further below), and the “typical” value given in Table 1 is consistent 
with recent measurements in animal models (Ances et al., 2001; 
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of the flow change, and not on the details of how the flow change 
is evoked. A key question that needs to be addressed is whether this 
relationship is the same for CBF changes induced by hypercapnia 
and neural activity.
In contrast to α and β, the value of M is critical. In general, the 
Davis model is robust because many of the physiological variables 
that could have a strong effect on the BOLD response magnitude 
are essentially lumped into the parameter M. This includes physi-
ological parameters, such as baseline venous blood volume and 
hematocrit, but also aspects of the image acquisition, such as echo 
time and field strength, and even the way that a region of interest 
is selected for averaging. For this reason, the value of M must be 
measured in each experiment, and a dangerous pitfall is to assume 
a value of M reported in the literature and apply it to data collected 
in a different way (Chiarelli et al., 2007b; Leontiev et al., 2007; Lin 
et al., 2008).
The tissue pO2 model also has a number of simplifying assump-
tions that need to be tested. Clearly this model ignores many of 
the complexities of O2 transport in blood, such as a shift of p50 as 
CO2 diffuses into the blood, although these may be approximated 
by an appropriate choice of p50 and h (Gjedde, 2005a). Perhaps the 
most important question, though, is: Can the macroscopic effects 
be described in terms of the average pO2 values in blood and tis-
sue? That is, even for the simplest microscopic model, the Krogh 
cylinder, blood and tissue pO2 values have a large spatial variability 
(Mintun et al., 2001), and experimental measurements show a wide 
range of pO2 values, raising the question of whether it is even mean-
ingful to talk about a mean tissue pO2 (Ndubuizu and LaManna, 
2007). Note, though, that the relevant question is not whether pO2 
is uniform in tissue, which would be a possible assumption that 
could be used to derive Eq. 3. Instead, the question is whether a 
much more detailed microscopic description leads to predictions 
for the macroscopic variables that differ significantly from the pre-
dictions of the simpler macroscopic models. A promising avenue 
for addressing questions like these is to construct detailed models 
of the vascular tree from animal imaging data and use such realistic 
geometries to calculate oxygen transport (Fang et al., 2008). These 
simulations also should include known effects of blood transport, 
such as the shift of p50, and so need to model CO2 production and 
clearance simultaneously with O2 transport and consumption. In 
addition, such simulations could also test assumptions of the PET 
models used for estimation of CMRO2, particularly the significance 
of the assumption of zero back flux of unmetabolized O2 from the 
tissue. While such modeling is computationally demanding, it is 
not out of reach, and recent studies are encouraging.
Dynamic responses
One of the exciting aspects of oxygenation-based methods, com-
pared with tracer methods, is the possibility of measuring dynamic 
CMRO2 changes. However, the theoretical framework described 
in Table 1 is based on steady-state relationships, and it is an open 
question whether these equations are accurate for dynamic studies. 
For example, Eq. 1 is intrinsically a steady-state equation because 
the net extraction fraction is the result of the full passage of the 
blood through the vascular bed, which requires a finite time. To 
deal with this issue, more detailed models are required that care-
fully take into account the dynamics of different compartments, 
played by blood volume changes (at all levels of the vascular tree) 
on the observed BOLD response. In applying the Davis model the 
exponent α = 0.4 is almost always used, with the assumption that 
this captures the volume change of blood compartments containing 
deoxyhemoglobin (primarily venous). However, this value origi-
nally came from whole-brain measurements of total blood volume 
changes in an animal model. A more recent study using PET meth-
ods in human subjects found larger values (as high as α = 0.64) 
(Rostrup et al., 2005), and a recent study in humans with the VASO 
technique also found values as high as α ∼ 0.6 (Lin et al., 2008, 
2009). It should be noted, though, that the VASO technique meas-
ures an absolute total blood volume change with activation, and a 
baseline value for blood volume must be assumed to estimate α. 
However, these methods measure total blood volume changes, and 
the primary quantity we need for interpreting the BOLD response 
is the venous volume change. A recent study using a novel method 
specifically sensitive to the venous blood found α ∼ 0.2 (Chen and 
Pike, 2009a), smaller than the previously reported values for total 
blood volume but still greater than 0.
A number of investigators are attacking the question of deter-
mining the volume changes in different vascular compartments 
with a variety of techniques in animal models. Two photon micro-
scopy studies, which allow direct visualization of the vessels and 
accurate measurement of vessel diameters in the upper 0.5 mm 
of cortex in rats and mice, have found that the volume changes 
are primarily on the arterial side, with relatively small changes in 
venous blood volume (Hillman et al., 2007). In addition, a number 
of MRI techniques have been developed to estimate volume changes 
in different vascular compartments, but it remains a challenging 
task to clearly isolate specific compartments from each other and 
from confounding flow effects. Several of these studies in animal 
models also found that most of the blood volume change is on the 
arterial side (Kim and Kim, 2006; Kim et al., 2007). More studies 
are clearly needed to clarify how blood volume changes with acti-
vation, but a working model based on these results is that most of 
the change is arterial, with smaller fractional changes in the venous 
and possibly the capillary compartments.
As noted above, the parameter β was initially introduced to 
approximate the net effect of smaller and larger vessels in describing 
the extravascular BOLD effect. It turns out fortuitously that this 
form also gives a reasonable description of the BOLD response 
when intravascular signal changes and volume exchange effects are 
included (Buxton et al., 2004; Leontiev et al., 2007). For this reason 
it may be better to look at β as a parameter that captures multiple 
effects, and no longer think of it in terms of the original derivation. 
A more detailed model of the BOLD response including multiple 
vascular compartments and effects could be used to estimate the 
value of β that maximizes the accuracy of the Davis model.
Although the concerns about which values of α and β should be 
used need to be addressed, it turns out that estimates of fractional 
CMRO2 change in a calibrated-BOLD experiment are relatively 
robust to uncertainties in α and β. The primary reason for this 
is that if the same model is used to analyze both the hypercapnia 
experiment and the activation experiment, the calculation is par-
tially self-correcting (Davis et al., 1998; Ances et al., 2008). However, 
this robustness is based on the assumption that the relationship 
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other studies using different techniques have not found evidence 
for a slow recovery of blood volume (Lu et al., 2004; Hillman et al., 
2007; Frahm et al., 2008). The BOLD post-stimulus undershoot in 
the absence of a slow venous recovery could be due a slow recovery 
of CMRO2 as noted above, although there is no direct evidence for 
this. Instead, this explanation remains when the possibilities of a 
slow blood volume recovery or a CBF undershoot are excluded. 
However, Figure 2 suggests that a weak undershoot of CBF would 
be sufficient to explain a more substantial BOLD undershoot, 
and in practice it may be difficult to exclude such a possibility 
because of the noise in the measurements. In short, an important 
physiological question that needs to be resolved in establishing a 
theoretical framework is whether blood volume changes are being 
accurately modeled.
current experImental measurements of the 
couplIng of cbf and cmro2
In addition to PET studies of the coupling of CBF and CMRO2 
(Fox and Raichle, 1986; Fox et al., 1988; Marrett and Gjedde, 1997; 
Ito et al., 2005), several groups have adopted the calibrated-BOLD 
approach and reported values of the CBF/CMRO2 coupling index n 
in the range of about 2–4 (Davis et al., 1998; Hoge et al., 1999; Kim 
et al., 1999; Kastrup et al., 2002; St Lawrence et al., 2003; Stefanovic 
et al., 2004, 2005; Uludag and Buxton, 2004; Fujita et al., 2006; 
Chiarelli et al., 2007a; Leontiev and Buxton, 2007; Leontiev et al., 
2007; Ances et al., 2008, 2009; Perthen et al., 2008; Restom et al., 
2008; Lin et al., 2009). Other studies have used the framework of 
the calibrated-BOLD approach to argue that CBF and CMRO2 are 
coupled in a similar way in deactivations and activations (Shmuel 
et al., 2002; Stefanovic et al., 2004, 2005; Uludag et al., 2004; Pasley 
et al., 2007).
Figure 3 shows a sampling of current data in human subjects 
using  either  PET  or  calibrated-BOLD  techniques.  The  plotted 
points are representative values from the studies, and the symbols 
used reflect the brain area and the technique. Also plotted are lines 
of constant values of n, the ratio of the CBF and CMRO2 changes. 
Note that the word “coupling” is used here simply to describe the 
empirical ratio n, and does not necessarily imply a direct mecha-
nistic link between CBF and CMRO2. Instead, current ideas point 
to CBF and CMRO2 being driven in parallel by neural activity. For 
reference to Figure 2, the contour predicted for constant tissue 
pO2 also is plotted.
There is a considerable spread of the coupling ratios, with most 
measurements lying in the range n ∼ 2–4. The calibrated-BOLD 
measurements show the highest changes in CBF and CMRO2, and 
this could be due to reduced partial volume averaging of gray mat-
ter signals with the improved spatial resolution of MRI compared 
with PET. Overall, though, there does not appear to be a strong 
difference in the coupling ratio n between calibrated-BOLD and 
PET measurements. The original observation of the CBF/CMRO2 
mismatch by Fox and Raichle is one of the largest values of n found 
(∼6), but later PET studies found n ∼ 2 in other brain regions. 
Undoubtedly, some (perhaps most) of the variance in these data 
is due to the different methods used. However, there is a trend in 
this data for motor/somatosensory data to have the highest values 
of n, basal ganglia to have the lowest values, and visual areas to lie 
in the middle.
or explicitly consider an extended vascular network (Boas et al., 
2008). While such models may be too complex for routine use, they 
would provide a valuable test-bed for validating simpler models, 
such as the framework described here, and guide the development 
of more accurate macroscopic models that capture the dynamics. 
For these reasons, the dynamic curves in Figure 2 should be con-
sidered as suggestive of what the dynamics might look like, because 
they were calculated by assuming that the steady-state relationships 
apply at each time point, and this needs to be tested with the more 
detailed models.
In addition to these basic questions regarding the modeling, it 
is still an open question whether there are transient physiological 
changes that are not captured by the simple theoretical frame-
work. There is a reasonable consensus that the initial dip of the 
BOLD response reflects a faster rise of CMRO2 compared to CBF 
(Malonek and Grinvald, 1996; Devor et al., 2003), and the current 
framework captures that possibility (see Figure 2). However, there 
is no consensus on whether the post-stimulus BOLD undershoot 
is a neural, vascular or metabolic effect. Intriguing recent evidence 
suggests a neuronal modulation of the undershoot (Sadaghiani 
et al., 2009), but it has more commonly been hypothesized to be a 
biomechanical (Buxton et al., 1998; Mandeville et al., 1999; Chen 
and Pike, 2009b) or metabolic effect (Frahm et al., 1996, 2008; 
Lu et al., 2004. If the undershoot is due to a mismatch of CBF 
and CMRO2, then the current framework will capture the effect. 
For example, the undershoot could be due to a slow recovery of 
CMRO2 combined with a fast recovery of CBF, or a fast recovery 
of CMRO2 combined with an undershoot of CBF (the latter pos-
sibility is illustrated in Figure 2). However, another possibility is 
that transients of blood volume and blood flow are different, so 
that blood volume recovers slowly even though CBF and CMRO2, 
and thus intrinsic blood oxygenation, have returned to baseline. 
This effect is not captured by the current theoretical framework, 
because Eq. 2 assumes a fixed relationship between blood flow and 
blood volume given by a power law. For this reason, it is important 
to determine empirically whether this effect occurs.
Early MRI studies using MION, a magnetic agent that labels 
the blood plasma, found a slow recovery of blood volume with 
a duration that matched the BOLD post-stimulus undershoot 
and was longer than the recovery time of CBF (Mandeville et al., 
1998). This observation prompted two similar models – the balloon 
model (Buxton et al., 1998) and the delayed compliance model 
(Mandeville et al., 1999) – hypothesizing that a slow recovery 
of venous blood volume, elevating total dexoyhemoglobin even 
though blood oxygenation had returned to baseline, could account 
for the BOLD post-stimulus undershoot. Later studies with MION 
and higher spatial resolution found that the slow recovery of blood 
volume was primarily in the middle layers of cortex (Yacoub et al., 
2006; Zhao et al., 2007). Interestingly, though, the BOLD under-
shoot was present in the upper layers as well as the middle layers. 
This suggests that while a slow venous volume recovery could be a 
contributing factor, particularly in the middle layers, it cannot be 
a general explanation. The presence of a BOLD undershoot in the 
upper layers without a slow blood volume recovery suggests that 
there is also an alteration of blood oxygenation, presumably due 
to a mismatch of CBF and CMRO2 in the post-stimulus period 
(Yacoub et al., 2006). In contrast to the MION studies, though, Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 8  |  10
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In short, the variability of n poses a significant problem for the 
interpretation of BOLD signals. Specifically, the relative value of 
BOLD responses cannot be taken as a quantitative reflection of the 
relative values of the underlying physiological changes. Variability 
of n is consistent with the current idea that neural activity drives 
CBF and CMRO2 in parallel, and emphasizes the critical importance 
of understanding exactly which aspects of neural activity drive CBF 
and which create a demand for higher CMRO2.
open questIons
The phenomenon that a brief neural stimulus produces a robust, 
but delayed, increase of CBF (Figure 1) lies at the heart of many 
functional neuroimaging techniques, and yet we still do not have a 
clear picture of the mechanisms involved, or even of the physiologi-
cal function served by this response: why is it so large, why is it so 
fast, and does it have anything to do with oxygen metabolism? The 
experimental data, integrated within the theoretical framework, 
may provide a possible explanation. These questions are considered 
in this section, emphasizing the idea that tissue pO2 may be the key 
to understanding CBF/CMRO2 coupling.
why Is the cbf change so large?
As noted above, recent studies of the tissue pO2 response with neural 
activation have found interestingly complex wiggles. However, step-
ping back from these detailed fluctuations, a remarkable finding is 
that the fluctuations are relatively small. For example, with a visual 
stimulus in a cat model Thompson et al. (2003, 2004) found pO2 
fluctuations that were all less than about 5% of the baseline pO2. 
Other studies with electrical stimulation in rats have found larger 
variations of ∼20% (Ances et al., 2001; Offenhauser et al., 2005), 
In a study specifically comparing simultaneous activation of 
basal ganglia areas with a motor task and visual areas with a visual 
stimulus, Ances et al. (2008) found a significantly higher value of 
n in visual cortex (n ∼ 2.3) compared to basal ganglia (n ∼ 1.7). At 
first glance this degree of difference does not sound like it should 
be too important, but the effect on the BOLD response was striking. 
The ratio of the BOLD responses for these two tasks was ∼7, even 
though the ratio of the CMRO2 responses was only ∼2. Interestingly, 
this failure of the BOLD response to accurately reflect the under-
lying CMRO2 change was not due to a difference in the value of 
the scaling parameter M between the two regions, but rather due 
to the difference in n. The CBF response to hypercapnia was also 
larger in the visual area compared to basal ganglia, in parallel with 
the larger value of n associated with neural activation, suggest-
ing a generally greater responsiveness of the blood vessels in the 
visual areas. This data, in addition to the other data in Figure 3, 
suggests that the coupling ratio n may vary between brain regions 
within the same subject. In addition, recent experiments suggest 
that n varies within visual cortex with the frequency of a visual 
stimulus (Lin et al., 2008) and with time for a sustained stimulus 
(Lin et al., 2009).
Positron emission tomography studies have been reported 
with  a  wide  variation  in  the  coupling  of  CBF  and  CMRO2, 
including extreme cases of no change in CMRO2 with an activa-
tion CBF (Kuwabara et al., 1992), as well as variability with the 
duration (Mintun et al., 2002) or frequency (Vafaee et al., 1999; 
Vafaee and Gjedde, 2000) of a visual stimulus. Taken together, 
the available data suggest that n may vary between regions, and 
even within a region it may vary with stimulus amplitude or 
other characteristics.
Figure 3 | experimental measurements of CBF/CMrO2 coupling in 
human brain. PET measurements are indicated by open symbols, and 
calibrated-BOLD measurements are indicated by filled symbols. Different 
symbol shapes are used for different brain areas, as indicated. Lines of 
constant n are shown as dashed lines, and the solid red curve is the contour 
of constant tissue pO2 calculated from the theoretical framework and shown 
in Figure 2B. The fact that the points are all well above the line n = 1 produces 
the BOLD effect with activation. A speculation discussed in the text is that 
the function served by a large value of n is to prevent a fall in tissue pO2 as 
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One clear function of blood flow is to deliver the substrates of 
energy metabolism, glucose and oxygen, and clear the waste prod-
ucts, carbon dioxide and heat. Metabolic rates are usually expressed 
as moles per minute per gram of tissue, but it is useful to consider 
these rates referenced to a unit volume of tissue, rather than a 
unit mass, and the metabolic rate is then a concentration divided 
by time (mM/min). In the adult human brain, a typical glucose 
metabolic rate is about 0.3 mM/min (Chugani et al., 1987), and a 
typical concentration of glucose in brain is about 2 mM at normal 
plasma glucose levels (Gruetter et al., 1998). The time constant for 
depleting the glucose is thus on the order of several minutes, sug-
gesting that the regulation of blood flow on a time scale of seconds 
is not required to support glucose metabolism. Furthermore, if the 
O2 supply was somehow abruptly stopped but CMRGlc continued 
at the normal rate, lactate would accumulate at a rate of about 
0.6 mM/min, so a change of lactate concentration of only 1 mM 
would take on the order of 90 s to grow.
The CMRO2 is higher, about 1.6 mM/min (Ito et al., 2004), 
and the tissue concentration of O2 is lower. If the tissue pO2 
is ∼25 mmHg, a solubility of 0.0013 mM/mmHg gives an extravas-
cular O2 concentration of only ∼0.03 mM. Arterial blood has an 
O2 concentration of about 9 mM, so for a typical tissue blood 
volume fraction of 5% and a roughly 70% average hemoglobin 
saturation the intravascular O2 content in tissue is about 0.26 mM. 
The total O2 concentration in an element of tissue then is about 
0.3 mM, with most of that in the blood compartment. The time 
constant for depleting the available O2 is then on the order of 
10 s, much shorter than the equivalent time for depletion of 
glucose. Excluding the O2 in blood within a tissue element, the 
O2 concentration associated with baseline tissue pO2 would be 
depleted in ∼1 s at the baseline metabolic rate, providing some 
support for applying the steady-state theoretical framework to 
dynamic changes.
Blood flow also carries away CO2 and heat. Because CO2 rapidly 
equilibrates with bicarbonate ions, the total pool of CO2 in the brain 
is quite large, ∼25 mM. The CO2 production rate is close to the O2 
consumption rate, ∼1.6 mM/min, so the time constant for chang-
ing total CO2 is on the order of 10 min. Conceivably, though, pH 
changes could begin to become important on a shorter time scale, 
and a possible role for CO2 in the post-stimulus undershoot has 
recently been proposed (Yucel et al., 2009). If the heat produced 
by the metabolic reactions is not dissipated, the temperature of the 
brain could rise to a level that could impair brain function. About 
440 kJ of heat is released per mole of O2 metabolized, and the heat 
capacity of water is ∼4.2 J/g/°C (Yablonskiy et al., 2000). If the 
heat of metabolism was not cleared, the temperature would rise 
only ∼0.1°C in 40 s. Thus, while clearance of heat is an important 
function, it does not appear that this requires the fast CBF response 
observed with neural stimulation.
In short, if energy metabolism increased without a change in 
CBF, the time scales for significant changes in the concentrations 
of glucose, lactate, and CO2, as well as the temperature rise due to 
added heat, appear to be too long to require a fast CBF response, 
or to provide the signal for increasing CBF. On the other hand, the 
time scale for changes in pO2 is comparable, although perhaps a bit 
longer, than the observed CBF response, suggesting that a fast CBF 
response is necessary to prevent a drop of tissue pO2.
but conceivably the stimuli used were exceptionally strong com-
pared to normal physiological stimuli. In parallel to these animal 
studies, the PET and calibrated-BOLD studies shown in Figure 3 
indicate that the CBF/CMRO2 coupling ratio n is ∼2–4. The theo-
retical framework in Table 1 shows that these different experimental 
results are consistent with a simple picture: the observed CBF/
CMRO2 coupling ratio is approximately what is required to main-
tain a constant tissue pO2 (the contour of constant pO2 is plotted 
in Figure 3). Furthermore, the theoretical pO2 curve in Figure 2 
illustrates that complex fluctuations of tissue pO2, but of small 
magnitude, can occur as the dynamic curves of CBF and CMRO2 
response pass over and under the contour of constant pO2 in the 
CBF/CMRO2 plane.
This observation suggests the hypothesis that the existence of 
the BOLD effect – the apparent mismatch of CBF and CMRO2 
changes – could be the result of a homeostatic mechanism acting 
to prevent a fall of tissue pO2 despite changes in the metabolic rate. 
Based on the theoretical framework in Table 1, a CMRO2 increase 
of 20% with no change in CBF would lead to a 30% drop of tissue 
pO2, while a CBF change ∼2.5 times larger than the CMRO2 change 
would preserve tissue pO2 ∼25 mmHg. An earlier idea for why n is 
large was that O2 delivery is limited at baseline (Gjedde et al., 1991; 
Buxton and Frank, 1997), motivated by the previous assumption 
of the PET methods that the pO2 in tissue is near 0 so that back 
flux of O2 from tissue to blood is negligible (Mintun et al., 1984). 
In that case, because tissue pO2 cannot drop, and because there is 
no capillary recruitment, the only way to increase the O2 gradient 
from blood to tissue is to increase the blood pO2 by decreasing E. 
Valabregue et al. (2003) pointed out that relaxing the assumption 
of zero tissue pO2 gave more flexibility for CBF and CMRO2 to 
vary, and the pO2 measurements cited above support the idea that 
tissue pO2 is reasonably high. The current argument is in a sense 
an extension of the original oxygen limitation hypothesis, but now 
in terms of a non-zero tissue pO2 that is prevented from dropping 
lower, rather than a zero tissue pO2 that cannot drop. The required 
value of n needed to maintain tissue pO2 decreases for higher values 
of baseline tissue pO2.
why Is the cbf change so fast?
The argument above addresses the question of why n is large, but 
does not necessarily address why the CBF response is so fast. The 
dynamic example in Figure 2 essentially assumes that the time 
constants for adjustments of blood and tissue oxygenation are 
on the order of 1 s, and this needs to be tested with more detailed 
models, as discussed above. As a start in this direction, it is use-
ful to estimate the time constants for different aspects of energy 
metabolism as a guide to whether these components would require 
a fast CBF response, and whether they could potentially provide 
a rapid signal to drive the CBF response. It’s important to note 
that these time scales do not describe how quickly the glucose or 
O2 metabolic rates could change. Both metabolic rates are likely 
to be able to change on a very short time scale with no changes in 
the concentrations of glucose or oxygen, through changes in the 
activity of rate-limiting enzymes. Instead, these time constants 
reflect the speed with which an abrupt change in metabolic rate 
would translate into a change in concentration of the metabolic 
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the neurons that produce NO have been isolated to a class of 
  inhibitory GABA-ergic interneurons (Estrada and DeFelipe, 1998). 
This is an example of a mechanism that has an inhibitory effect 
on the neuronal population, and yet also increases blood flow. 
Adenosine is another prime example, reducing neuronal excitability 
while also acting as a vasodilator (Dirnagl et al., 1994; Haydon and 
Carmignoto, 2006). At first glance, this counterintuitive behavior 
is puzzling if the goal is to match blood flow to the level of neural 
activity. However, this combined effect makes sense as a protection 
against a potentially dangerous drop in tissue pO2, by both increas-
ing delivery and decreasing demand for O2. Both effects would 
serve to raise tissue pO2. This is consistent with the idea of oxygen 
conformance, that a primary defense of an organism when faced 
with hypoxia is to reduce the ATP consumption and O2 metabolic 
rate (Hochachka et al., 1996).
The existence of mechanisms that drive neural activity down 
while increasing CBF suggests the possibility that a greater involve-
ment of inhibitory activity could be associated with larger values 
of n. However, we should be cautious in interpreting these studies: 
the identification of a particular mechanism in simple preparations 
does not necessarily mean these mechanisms are dominant or even 
invoked in vivo. For example, interneurons also release neuropep-
tide Y (Abounader and Hamel, 1997), a vasoconstrictor, and astro-
cytes can trigger both vessel dilation and constriction (Zonta et al., 
2003; Mulligan and MacVicar, 2004; Blanco et al., 2008), and we 
have no clear picture of how these different potential mechanisms 
are integrated into a responsive system in vivo. Nevertheless, the 
possibility of significant variations in CBF/CMRO2 coupling related 
to inhibition is a potentially fruitful direction for future research.
In summary, the data and the theoretical modeling suggest the 
hypothesis that the underlying function served by n ∼ 2–3 is to 
approximately maintain tissue pO2 at a constant level. However, 
feed-forward  mechanisms  driven  by  the  neural  activity  itself, 
such as NO production, are likely required to achieve the fast CBF 
response necessary to prevent a fall in pO2. Furthermore, the spe-
cific interplay of different aspects of the evoked activity, such as the 
degree of evoked inhibitory activity, could alter the CBF/CMRO2 
coupling ratio. This speculative scenario needs to be tested with 
detailed studies in animal models of the specific aspects of neural 
activity that drive CBF changes, and how these relate to the overall 
energy demands of the full evoked activity. Finally, it is interesting to 
note that the hypothesis that tissue pO2 is approximately conserved 
during neural activation is consistent with a broader evolution-
ary hypothesis. Baseline pO2 levels in tissue are similar to what is 
thought to have been the atmospheric level of O2 two billion years 
ago, when the machinery of oxidative metabolism evolved. It has 
been hypothesized that organisms try to preserve this level of O2 
in tissues as a balance between too little, limiting O2 metabolism, 
and too much leading to increased generation of reactive oxygen 
species and potential cellular damage (Massabuau, 2003).
conclusIons
The basic picture of blood flow and oxygen metabolism being 
driven in parallel by neural activity – rather than a serial connection 
with neural activity driving energy metabolism which then drives 
blood flow changes – creates a significant challenge for interpret-
ing many brain imaging signals in a quantitative way. The central 
what drIves the cbf change?
The  arguments  above  raise  two  key  questions:  why  does  the 
brain need to preserve tissue pO2, and what mechanisms could 
be involved in maintaining it? At first glance, it appears that the 
normal pO2 level (∼25 mmHg) is much higher than it needs to be, 
given that the effective Km for cytochrome oxidase, the O2 con-
centration where O2 availability limits CMRO2, is below 1 mmHg 
(Gnaiger et al., 1998). That is, it appears that CMRO2 should not 
be affected by transient dips in tissue pO2. However, there are two 
potential reasons why a higher pO2 may be important for healthy 
brain function. The first is that there are many other reactions for 
which O2 is a substrate, and these have much larger Km values than 
cytochrome oxidase (Vanderkooi et al., 1991; Erecinska and Silver, 
2001). For these reactions, fluctuations of tissue pO2 could affect 
the reaction rate. A second possible reason why maintaining a high 
tissue pO2 may be important is related to the thermodynamics of 
energy metabolism. The Gibbs free energy (∆G) available from 
oxidative metabolism of glucose depends on the O2 concentration. 
This ∆G must be sufficiently negative to offset the strong positive 
∆G required to produce ATP from ADP and Pi. If the ∆G of oxi-
dative metabolism is reduced because of low tissue pO2, there will 
be a point where CMRO2 cannot proceed unless the ∆G related 
to producing ATP also is reduced. This would be a reduction of 
the phosphorylation potential, the ratio [ATP]/[ADP][Pi]. This 
phenomenon was observed in cell cultures, where even though 
the rate of O2 metabolism could be maintained down to very low 
levels of pO2, the phosphorylation potential began to decrease at 
much higher levels (Wilson et al., 1979).
In the last decade there has been a surge of research on the 
mechanisms by which cells sense their oxygen level and respond 
with a wide range of physiological changes, particularly the cascade 
of events that follows stabilization of hypoxia-inducible factor-1 
(HIF-1, Semenza, 2009). While often considered in the context of 
responses to hypoxia, it is interesting to note that some of the inter-
mediate reactions are sensitive to the pO2 at higher levels (Ward, 
2008), and recent work suggests that these mechanisms may play 
a role in normoxia as well as hypoxia (Semenza, 2009). While it is 
conceivable that a pO2 feedback system may be involved in driv-
ing the acute CBF changes with activation, it is not clear that these 
mechanisms could operate effectively on the time scale of a few 
seconds. Such mechanisms, like other metabolic influences, may 
operate on a longer time scale to match CBF with energy demands. 
For this reason, the immediate trigger for the CBF increase most 
likely operates in a feed-forward fashion, with aspects of neural 
activity triggering an initial response that is then modulated by 
slower feedback responses. A great deal of experimental evidence 
has supported a role for astrocytes in modulating CBF, acting as 
both an integrator of local synaptic activity and an effector of blood 
flow change (Iadecola and Nedergaard, 2007). However, it is still 
not clear whether astrocyte responses are fast enough to drive CBF 
changes on a time scale of seconds, as the time scale observed for 
vascular responses in slice preparations is much longer than what 
is observed in awake humans (Koehler et al., 2009).
One mechanism that has been observed to respond quickly 
enough to drive the CBF response is the production of NO (Buerk 
et al., 2003). While NO is produced by vascular and endothelial 
mechanisms, it also is produced by neurons. Interestingly, though, Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 8  |  13
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